valine and transforming growth factor beta

valine has been researched along with transforming growth factor beta in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (7.69)18.2507
2000's18 (69.23)29.6817
2010's6 (23.08)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandan, E; Broszat, M; Bruckner, P; Kresse, H; Schönherr, E1
Bieringer, M; Breu, V; Dechend, R; Fiebeler, A; Haller, H; Luft, FC; Müller, DN; Park, JK; Schmidt, F; Shagdarsuren, E1
Hannan, RD; Krum, H; Lim, S; See, F; Tzanidis, A; Ugoni, AM1
Lau, CP; Tipoe, GL; Wing-Hon Lai, K; Yu, CM1
Cooper, ME; Cox, AJ; Gilbert, RE; Kelly, DJ; Tolcos, M; Wilkinson-Berka, JL1
Lin, S; Wen, H1
Dagistanli, FK; Erek, E; Kalender, B; Oztürk, M; Tunçdemir, M; Uysal, O; Yegenaga, I1
Du, YC; Xu, JY; Zhang, SJ1
Banfi, C; Brioschi, M; Crippa, V; de Gasparo, M; Gelosa, P; Gianazza, E; Gianella, A; Guerrini, U; Nobili, E; Sironi, L; Tremoli, E1
Gong, ZJ; Huang, YQ; Ruan, P; Song, SL1
Khalil, N; Mancini, GB1
Liu, F; Xu, QY; Ye, YQ1
Gray, PC; Harrison, CA; Lewis, KA; Vale, WW; Wiater, E1
Ramirez-Miranda, A; Santacruz-Valdes, C; Suarez-Sanchez, R; Zenteno, JC1
Gong, HP; Li, L; Ma, X; Miao, Y; Sun, H; Zhang, W; Zhang, Y; Zhong, M1
Akdag, I; Filiz, G; Gullulu, M; Kahvecioglu, S; Savci, V1
Afshari, NA; Bahadur, RP; Eifrig, DE; Enghild, JJ; Klintworth, GK; Thogersen, IB1
Chen, N; Shi, H; Shi, W; Wang, W; Yu, H; Zhang, B1
He, Y; Huang, Q; Jiang, J; Li, M; Liu, X; Ma, D; Wang, S; Xu, G; Yao, Y; Zhou, J; Zou, R1
Akashiba, A; Ishimitsu, T; Matsuoka, H; Ono, H; Ono, Y1
Dong, YF; Fukuda, M; Kataoka, K; Kim-Mitsuyama, S; Lai, ZF; Liu, L; Nakamura, T; Nako, H; Ogawa, H; Tokutomi, Y; Yamamoto, E1
Bisceglia, L; De Bonis, P; Laborante, A; Longo, C1
Huang, CY; Lin, HB; Wang, DM; Wang, L; Yan, L; Yan, W; Yin, NB; Yu, J; Zhang, F; Zhang, LL; Zhao, ZM1
Greer, T; Kent, KC; Li, L; Lietz, CB; Shi, X; Yu, Q1
Chiu, SY; Chung, HJ; Huang, CC; Huang, MS; Lin, Y; Liu, F; Matsuura, I; Yadav, P1
Gaballah, AH; Ghazy, AA; Mostafa, H; Osman, EM; Rashwan, EA; Tawfik, S1

Other Studies

26 other study(ies) available for valine and transforming growth factor beta

ArticleYear
Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen.
    Archives of biochemistry and biophysics, 1998, Jul-15, Volume: 355, Issue:2

    Topics: Binding Sites; Binding, Competitive; Chromatography, Gel; Collagen; Decorin; Extracellular Matrix Proteins; Humans; Immune Sera; Immunoglobulin Fab Fragments; Leucine; Monocytes; Peptide Fragments; Protein Binding; Proteoglycans; Recombinant Proteins; Transforming Growth Factor beta; Tumor Cells, Cultured; Valine

1998
Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury.
    Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:2 Pt 2

    Topics: Aldosterone; Angiotensin II; Animals; Animals, Genetically Modified; Blood Pressure; Body Weight; Cardiovascular Diseases; Fibroblast Growth Factor 2; Heart; Immunohistochemistry; Mineralocorticoid Receptor Antagonists; NF-kappa B; Organ Size; Platelet-Derived Growth Factor; Rats; Receptors, Mineralocorticoid; Renin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Tetrazoles; Transcription Factor AP-1; Transforming Growth Factor beta; Valine; Valsartan

2001
Combined angiotensin and endothelin receptor blockade attenuates adverse cardiac remodeling post-myocardial infarction in the rat: possible role of transforming growth factor beta(1).
    Journal of molecular and cellular cardiology, 2001, Volume: 33, Issue:5

    Topics: Angiotensin Receptor Antagonists; Animals; Blotting, Northern; Bosentan; Collagen; Endothelin Receptor Antagonists; Female; Fibroblasts; Hemodynamics; Hypertrophy, Left Ventricular; Immunohistochemistry; Macrophages; Monocytes; Myocardial Infarction; Myocardium; Procollagen; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Valine; Valsartan; Ventricular Dysfunction, Left

2001
Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction.
    Journal of the American College of Cardiology, 2001, Volume: 38, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Collagen; Drug Combinations; Fibrosis; Fosinopril; Male; Myocardial Infarction; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Valine; Valsartan; Ventricular Remodeling

2001
Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
    Kidney international, 2002, Volume: 61, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Apoptosis; Atrophy; Autoradiography; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epidermal Growth Factor; Female; Fibrosis; Gene Expression; In Situ Hybridization; In Situ Nick-End Labeling; Kidney Tubules; Nephritis, Interstitial; Perindopril; Rats; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan

2002
[Renal protective effect of valsartan in diabetic rats].
    Zhonghua nei ke za zhi, 1999, Volume: 38, Issue:3

    Topics: Animals; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Fibronectins; Kidney; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Valine; Valsartan

1999
Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Acta histochemica, 2002, Volume: 104, Issue:2

    Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Female; Immunoenzyme Techniques; Immunohistochemistry; Kidney; Organ Size; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan

2002
Effects of angiotensin II receptor antagonist on expression of collagen III, collagen V, and transforming growth factor beta1 in the airway walls of sensitized rats.
    Chinese medical journal, 2004, Volume: 117, Issue:6

    Topics: Angiotensin Receptor Antagonists; Animals; Asthma; Bronchi; Collagen Type III; Collagen Type V; Immunization; Male; Ovalbumin; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan

2004
Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Blood Pressure; Body Weight; Brain; Chemokine CCL2; Immunohistochemistry; Interleukin-1; Kidney; Magnetic Resonance Imaging; Male; Proteinuria; Rats; Rats, Inbred SHR; RNA, Messenger; Stroke; Survival Analysis; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan

2004
[Effects of perindopril and valsartan on the expression of TGF beta 1 and TGF beta receptor II mRNA, Smad3 and Smad7 in experimental hepatic fibrotic rats].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2004, Volume: 12, Issue:12

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Female; Liver Cirrhosis, Experimental; Male; Perindopril; Random Allocation; Rats; Rats, Wistar; Receptors, Transforming Growth Factor beta; RNA, Messenger; Smad3 Protein; Smad7 Protein; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Valine; Valsartan

2004
Angiotensin II type 1 receptor blocker inhibits pulmonary injury.
    Clinical and investigative medicine. Medecine clinique et experimentale, 2005, Volume: 28, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Antimetabolites, Antineoplastic; Bleomycin; Blotting, Western; Collagen; Connective Tissue Growth Factor; Enzyme-Linked Immunosorbent Assay; Female; Fibrosis; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lung; Macrophages; Rats; Rats, Sprague-Dawley; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Valine; Valsartan

2005
[Effects of valsartan on bleomycin-induced pulmonary fibrosis in rats and the expression of hepatocyte growth factor in lung tissue].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2005, Volume: 28, Issue:7

    Topics: Animals; Hepatocyte Growth Factor; Lung; Male; Pulmonary Fibrosis; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan

2005
Identification of distinct inhibin and transforming growth factor beta-binding sites on betaglycan: functional separation of betaglycan co-receptor actions.
    The Journal of biological chemistry, 2006, Jun-23, Volume: 281, Issue:25

    Topics: Amino Acid Sequence; Binding Sites; Cell Line, Tumor; Humans; Inhibins; Molecular Sequence Data; Mutation; Protein Binding; Protein Structure, Tertiary; Proteoglycans; Receptors, Transforming Growth Factor beta; Sequence Homology, Amino Acid; Transforming Growth Factor beta; Valine

2006
Expanding the mutational spectrum in TGFBI-linked corneal dystrophies: Identification of a novel and unusual mutation (Val113Ile) in a family with granular dystrophy.
    Molecular vision, 2006, Apr-10, Volume: 12

    Topics: Adenine; Adult; Base Sequence; Corneal Dystrophies, Hereditary; Corneal Opacity; Corneal Stroma; Extracellular Matrix Proteins; Female; Guanine; Heterozygote; Humans; Isoleucine; Mutation, Missense; Transforming Growth Factor beta; Valine

2006
[Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
    Zhonghua yi xue za zhi, 2006, Jan-24, Volume: 86, Issue:4

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Cardiomyopathy, Hypertrophic; Diabetes Mellitus, Experimental; Fibrosis; Heart; Male; Myocardium; Random Allocation; Rats; Rats, Wistar; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tetrazoles; Thrombospondin 1; Transforming Growth Factor beta; Valine; Valsartan

2006
Aldosterone blockage in proliferative glomerulonephritis prevents not only fibrosis, but proliferation as well.
    Renal failure, 2006, Volume: 28, Issue:6

    Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Cell Proliferation; Disease Models, Animal; Diuretics; Fibrosis; Glomerulonephritis, Membranoproliferative; Ki-67 Antigen; Kidney; Mineralocorticoid Receptor Antagonists; Rats; Rats, Sprague-Dawley; Spironolactone; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan

2006
Atypical asymmetric lattice corneal dystrophy associated with a novel homozygous mutation (Val624Met) in the TGFBI gene.
    Molecular vision, 2008, Mar-12, Volume: 14

    Topics: Base Sequence; Corneal Dystrophies, Hereditary; Extracellular Matrix Proteins; Homozygote; Humans; Male; Methionine; Middle Aged; Mutation; Transforming Growth Factor beta; Valine

2008
Peritubular capillary loss is ameliorated by ramipril or valsartan treatment.
    Microcirculation (New York, N.Y. : 1994), 2008, Volume: 15, Issue:4

    Topics: Animals; Antihypertensive Agents; Capillaries; Gene Expression Regulation; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Tubules; Male; Microcirculation; Ramipril; Rats; Rats, Sprague-Dawley; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan

2008
Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgamma.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2008, Volume: 28, Issue:5

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cells, Cultured; Extracellular Matrix; Glomerulosclerosis, Focal Segmental; Mesangial Cells; PPAR gamma; Rats; Telmisartan; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan

2008
Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats.
    Journal of cardiology, 2008, Volume: 52, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Caspase 3; Fibrosis; Hypertension; Male; Myocardium; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; RNA; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan; Ventricular Remodeling

2008
Aliskiren enhances protective effects of valsartan against type 2 diabetic nephropathy in mice.
    Journal of hypertension, 2010, Volume: 28, Issue:7

    Topics: Albuminuria; Amides; Animals; Collagen Type IV; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Synergism; Fumarates; Kidney Glomerulus; Losartan; Male; Mice; Mice, Inbred C57BL; Tetrazoles; Transforming Growth Factor beta; Valine; Valsartan

2010
Lattice Corneal Dystrophy-Variant: a report of three new cases due to p.V631D mutation in the TGFBI gene.
    La Clinica terapeutica, 2013, Volume: 164, Issue:1

    Topics: Aspartic Acid; Biomarkers; Corneal Dystrophies, Hereditary; Early Diagnosis; Extracellular Matrix Proteins; Humans; Point Mutation; Prognosis; Transforming Growth Factor beta; Valine

2013
Transcriptome analysis of skin photoaging in chinese females reveals the involvement of skin homeostasis and metabolic changes.
    PloS one, 2013, Volume: 8, Issue:4

    Topics: Adult; Cluster Analysis; Computational Biology; Female; Gene Expression Profiling; Gene Expression Regulation; Homeostasis; Humans; Isoleucine; Leucine; Metabolic Networks and Pathways; Middle Aged; Molecular Sequence Annotation; Signal Transduction; Skin; Skin Aging; Sunlight; Transforming Growth Factor beta; Valine

2013
Evaluation and Application of Dimethylated Amino Acids as Isobaric Tags for Quantitative Proteomics of the TGF-β/Smad3 Signaling Pathway.
    Journal of proteome research, 2016, 09-02, Volume: 15, Issue:9

    Topics: Alanine; Amino Acids; Animals; HEK293 Cells; Humans; Leucine; Methylation; Mice; Muscle, Smooth, Vascular; Proteomics; Signal Transduction; Smad3 Protein; Staining and Labeling; Transforming Growth Factor beta; Valine

2016
Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation site.
    Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:11

    Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Proliferation; Female; Gene Editing; Gene Knock-In Techniques; Humans; Lung Neoplasms; Mice; Mice, SCID; Phosphorylation; Point Mutation; Signal Transduction; Smad3 Protein; Threonine; Transforming Growth Factor beta; Triple Negative Breast Neoplasms; Valine; Xenograft Model Antitumor Assays

2018
Relation between microRNA-21, transforming growth factor β and response to treatment among chronic hepatitis C patients.
    Journal of medical virology, 2019, Volume: 91, Issue:12

    Topics: Adult; Antiviral Agents; Biomarkers; Carbamates; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Male; MicroRNAs; Middle Aged; Prospective Studies; Pyrrolidines; Ribavirin; Sofosbuvir; Transforming Growth Factor beta; Treatment Outcome; Valine; Viral Load

2019